Literature DB >> 12642870

Mutations of TP53 induce loss of DNA methylation and amplification of the TROP1 gene.

Ashraf F Nasr1, Michele Nutini, Barbara Palombo, Emanuela Guerra, Savenio Alberti.   

Abstract

p53 and DNA methylation play key roles in the maintenance of genome stability. In this work, we demonstrate that the two mechanisms are linked and that p53 plays a role in the maintenance of the DNA methylation levels. The loss of p53 was shown to induce loss of DNA methylation in the TROP1 gene, a human cancer-expressed locus that undergoes amplification when hypomethylated. This demethylation was reverted by the reintroduction of a wild-type TP53 (wtTP53) in the TP53-null cells. Using a gene-amplification assay in vivo, we demonstrate that the loss of p53 leads to a demethylation-dependent TROP1 gene amplification. The induction of gene amplification was reverted by the expression of a wtTP53 gene or by in vitro methylation of the transfected DNA with the Sss I DNA methylase. Taken together, these findings demonstrate that the inactivation of TP53 induces loss of DNA methylation and DNA methylation-dependent gene amplification.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642870     DOI: 10.1038/sj.onc.1206248

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Genome-wide CpG island methylation and intergenic demethylation propensities vary among different tumor sites.

Authors:  Seung-Tae Lee; Joseph L Wiemels
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971

2.  Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters.

Authors:  Pierre-Olivier Estève; Hang Gyeong Chin; Sriharsa Pradhan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

3.  Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion.

Authors:  Narendra V Sankpal; Michael W Willman; Timothy P Fleming; John D Mayfield; William E Gillanders
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

4.  A seven-gene CpG-island methylation panel predicts breast cancer progression.

Authors:  Yan Li; Anatoliy A Melnikov; Victor Levenson; Emanuela Guerra; Pasquale Simeone; Saverio Alberti; Youping Deng
Journal:  BMC Cancer       Date:  2015-05-19       Impact factor: 4.430

5.  TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.

Authors:  Khadija Rebbani; Agnès Marchio; Sayeh Ezzikouri; Rajaa Afifi; Mostafa Kandil; Olfa Bahri; Henda Triki; Abdellah Essaid El Feydi; Anne Dejean; Soumaya Benjelloun; Pascal Pineau
Journal:  Mol Cancer       Date:  2015-04-02       Impact factor: 27.401

6.  p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.

Authors:  Emanuela Guerra; Alessia Cimadamore; Pasquale Simeone; Giovanna Vacca; Rossano Lattanzio; Gerardo Botti; Valentina Gatta; Marco D'Aurora; Barbara Simionati; Mauro Piantelli; Saverio Alberti
Journal:  BMC Cancer       Date:  2016-08-18       Impact factor: 4.430

7.  Significant associations between driver gene mutations and DNA methylation alterations across many cancer types.

Authors:  Yun-Ching Chen; Valer Gotea; Gennady Margolin; Laura Elnitski
Journal:  PLoS Comput Biol       Date:  2017-11-10       Impact factor: 4.475

Review 8.  Epigenetic inheritance and the missing heritability.

Authors:  Marco Trerotola; Valeria Relli; Pasquale Simeone; Saverio Alberti
Journal:  Hum Genomics       Date:  2015-07-28       Impact factor: 4.639

9.  Epigenetic heredity of human height.

Authors:  Pasquale Simeone; Saverio Alberti
Journal:  Physiol Rep       Date:  2014-06-24

10.  PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.

Authors:  Wei Xia; Hansong Bai; Ying Deng; Yi Yang
Journal:  J Cell Mol Med       Date:  2020-09-27       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.